Browsing Centre for Biochemical Pharmacology by Author "Keeling, N"
Now showing items 1-1 of 1
-
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis, R; Harrison, TW; Chanez, P; Menzella, F; Philteos, G; Cosio, BG; Lugogo, NL; de Luiz, G; Burden, A; Adlington, T (2023-06)BACKGROUND: The phase IIIb, randomized, parallel-group, placebo-controlled ANDHI double-blind (DB) study extended understanding of the efficacy of benralizumab for patients with severe eosinophilic asthma. Patients from ...